Clinical trials – Page 2
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
BusinessVaccine approvals offer hope as global Covid cases surge
A handful of vaccines are now approved and the first doses are being given to patients, with trials for many more candidates nearing completion
-
ResearchExplainer: How would UK science be affected by a no-deal Brexit?
Access to EU science schemes, freedom of movement and student places are all expected to be disrupted
-
-
BusinessOxford–AstraZeneca vaccine joins others with promising interim data
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease
-
BusinessRegulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
BusinessModerna and Pfizer’s Covid-19 vaccines add more encouraging data
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
-
ArticleThe future is bright: protecting innovation during uncertain times
The annual Pharma Integrates event facilitates conversation and collaboration to drive future innovation and improve patient outcomes worldwide
-
OpinionThe ins and outs of vaccine trials
Derek Lowe lays out how the trials work, and why they get paused and restarted
-
NewsFirst Covid-19 challenge study working with live virus planned for the UK
Pending ethics panel approval, healthy volunteers would be infected with Sars-CoV-2 to help understand disease and test vaccines
-
BusinessProtein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
BusinessRussian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
NewsDoes hydroxychloroquine still have a role to play in this pandemic?
Touted as a wonder drug by some its star now appears to be on the wane
-
BusinessWhat are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
NewsCovid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change
-
OpinionHopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
OpinionDoes the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
-
OpinionVaccine development against the clock
How long will it take to develop a coronavirus vaccine and why is it so hard?
-
BusinessCan existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work